The RBP HuR was discovered to promote the growth of cervical cancer cells by interaction with the 3'UTR of RBP nucleolin (NCL) mRNA, which specifically promoted the translation of NCL without the alteration of NCL mRNA levels [48]. This evidence concerns the gene NUCLEOLIN and cervical cancer.